IL-1Ra Elaboration by Colchicine Stimulation in Normal Human Bronchial Epithelial Cells / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
; : 145-153, 2007.
Article
en Ko
| WPRIM
| ID: wpr-139598
Biblioteca responsable:
WPRO
ABSTRACT
BACKGROUND: Asthma is a syndrome that is characterized by a variable degree of airflow obstruction, bronchial hyperresponsiveness, and airway inflammation. Colchicine is an inexpensive and safe medication with unique anti- inflammatory properties. IL-1Ra (Interleukin-1 receptor antagonist) mediates the anti-inflammatory effect in human inflammatory diseases, including asthma. This study examined whether IL-1Ra mediates the anti-inflammatory effect of colchicine in normal human bronchial epithelial cells (NHBE), RAW 264.7 cells (murine macrophage cell line), and a mouse lung. METHODS: NHBE, RAW 264.7 cells and BALB/c mice were stimulated with colchicine, and the increase in the IL-1Ra level was estimated by ELISA, Western analysis and RT-PCR analysis. RESULTS: Colchicine stimulated NHBE and RAW 264.7 cells to release IL-1Ra into the supernatant in a dose-and time-dependent manner. The major isoform of IL-1Ra in NHBE and RAW 264.7 cells is type I icIL-1Ra, and sIL-1Ra, respectively. IL-1Ra up-regulation was blocked by PD98059, a specific inhibitor in MAPK pathways. Colchicine also stimulated the secretion of IL-1Ra into the bronchoalveolar lavage (BAL) fluid of BALB/c mouse. CONCLUSION: Colchicine stimulates an increase in the IL-1Ra level both in vivo and in vitro, and might have an anti-inflammatory effect.
Palabras clave
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Asma
/
Ensayo de Inmunoadsorción Enzimática
/
Regulación hacia Arriba
/
Colchicina
/
Lavado Broncoalveolar
/
Células Epiteliales
/
Proteína Antagonista del Receptor de Interleucina 1
/
Inflamación
/
Pulmón
/
Macrófagos
Límite:
Animals
/
Humans
Idioma:
Ko
Revista:
Tuberculosis and Respiratory Diseases
Año:
2007
Tipo del documento:
Article